Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for Temecula Valley Hospital located at 31700 Temecula Pkwy, Temecula, CA, 92592 & includes data from NPIs 1679816201
Dexur analyzed Q1 2017 (January to March 2017) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for Temecula Valley Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Jan 2017 to Mar 2017) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 709 | 654 | ||||||||||
| Surgical | 182 | 172 | ||||||||||
| Non Surgical | 527 | 482 | ||||||||||
| Cardiovascular | 211 | 190 | ||||||||||
| Gastroenterology & Endocrinology | 93 | 89 | ||||||||||
| Orthopedics | 84 | 82 | ||||||||||
| Pulmonology | 80 | 78 | ||||||||||
| General Medicine | 73 | 65 | ||||||||||
| Urology | 63 | 59 | ||||||||||
| Neurology | 35 | 30 | ||||||||||
| General Surgery | 34 | 30 | ||||||||||
| Oncology & Hematology | 24 | 21 |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Jan 2017 to Mar 2017) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Jan 2017 to Mar 2017) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Jan 2017 to Mar 2017) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Jan 2017 to Mar 2017) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||
| Bronchitis And Asthma |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Jan 2017 to Mar 2017) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Jan 2017 to Mar 2017) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Renal Failure | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Jan 2017 to Mar 2017) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Jan 2017 to Mar 2017) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders | ||||||||||||
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |